Treatment becomes more complex when both rheumatism (RA) and diabetes are chronic diseases. Rheumatism is an autoimmune disease, mainly manifested in arthritis and pain, while diabetes is a metabolic disease characterized by high blood sugar. When they coexist, a combination of treatment programmes is needed to effectively control the situation and improve the quality of life of patients.
I. Drug treatment: For rheumatism, commonly used drugs include inflammation drugs (NSAIDs), sugar cortex hormones and rheumatoids. NSAIDs, such as Bloofen, Sieve, etc. can alleviate pain and inflammation. Sugar cortex hormones, such as Penneson, have a strong anti-inflammation effect, but long-term use requires attention to its side effects. The anti-generic damp medicine, such as ammonium butterflies and fluorine, inhibits the immune response and controls progress. Diabetes treatment focuses on the control of blood sugar, and commonly used drugs include oral sugar and insulin. Oral sugar herbs, such as diaphragms, Gretzitt, can improve insulin sensitivity or promote insulin distribution. Insulin is used as an alternative to insulin for patients with insulin deficiency.
II. Lifestyle intervention: Lifestyle adaptation benefits both. First, a balanced diet is essential. Patients should reduce intake of high sugar and fat food and increase the proportion of vegetables, fruit and whole grains to maintain healthy weight and blood sugar levels. Second, appropriate motion increases physical metabolism and insulin sensitivity, while also helping to reduce the joint burden. It is recommended to select low-impact sports such as walking, yoga, etc.
iii. Regular monitoring and adjustment of treatment programmes: Both rheumatism and diabetes are subject to regular monitoring of indicators such as blood sugar, sugarated haemoglobins, rheumatist factors and C-reactive proteins. Based on the results of the monitoring, treatment programmes are adjusted in a timely manner to ensure effective control of the condition.
IV. Attention to complications and complications: Patients with combined cardiac, kidney and other complications of rheumatism. The risks of these complications therefore require special attention and timely preventive measures. At the same time, there should be active treatment, reduction of symptoms and improvement of the quality of life for the combinations that have emerged, such as diabetes mellitus and arthritis-induced joint malformations.
Psychological support: The treatment of chronic diseases is lengthy and patients may face greater psychological stress. Thus, psychological support to help patients build confidence in overcoming disease is an integral part of treatment programmes.
In the light of the above, the treatment of rub-wet arthritis combined with diabetes requires a combination of drug treatment, lifestyle interventions, regular monitoring and adjustment programmes and psychological support. The quality of life of patients can be improved by effective control of the condition through scientific and comprehensive treatment.
